Intricate link between siderophore secretion and drug efflux in Mycobacterium tuberculosis.
Intricate link between siderophore secretion and drug efflux in Mycobacterium tuberculosis.
复制标题
结核分枝杆菌铁载体分泌与药物流出之间的复杂联系。
DOI:
10.1128/aac.01629-22
复制
发表时间:
2023
影响因子:
4.9
通讯作者:
Niederweis,Michael
中科院分区:
文献类型:
--
作者:
Meikle,Virginia;Zhang,Lei;Niederweis,Michael
Drug-resistantMycobacterium tuberculosisis a worldwide health-care problem rendering current tuberculosis (TB) drugs ineffective. Drug efflux is an important mechanism in bacterial drug resistance. The MmpL4 and MmpL5 transporters form functionally redundant complexes with their associated MmpS4 and MmpS5 proteins and constitute the inner membrane components of an essential siderophore secretion system ofM. tuberculosis. Inactivating siderophore secretion is toxic forM. tuberculosisdue to self-poisoning at low-iron conditions and leads to a strong virulence defect in mice. In this study, we show thatM. tuberculosismutants lacking components of the MmpS4-MmpL4 and MmpS5-MmpL5 systems are more susceptible to bedaquiline, clofazimine, and rifabutin, important drugs for treatment of drug-resistant TB. While genetic deletion experiments revealed similar functions of the MmpL4 and MmpL5 transporters in siderophore and drug secretion, complementation experiments indicated that the MmpS4-MmpL4 proteins alone are not sufficient to restore drug efflux in anM. tuberculosismutant lacking both operons, in contrast to MmpS5-MmpL5. Importantly, anM. tuberculosismutant lacking the recently discovered periplasmic Rv0455c protein, which is also essential for siderophore secretion, is more susceptible to the same drugs. These results reveal a promising target for the development of dual-function TB drugs, which might poisonM. tuberculosisby blocking siderophore secretion and synergize with other drugs by impairing drug efflux.